EMEA-002588-PIP01-19
Key facts
| Active substance |
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0396/2019
|
| PIP number |
EMEA-002588-PIP01-19
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Pharmaceutical Oriented Services Ltd
E-mail: emakrodouli@pharosgr.gr; skoukaki@pharosgr.gr |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|